SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: DAVID who wrote (5406)2/10/1998 10:12:00 PM
From: Tunica Albuginea  Respond to of 23519
 
I believe Vivus will make $2 in 98 due to giant sales in Q2 and Q3 both in the US and Europe. In no way will Viagra be able to stimulate dying capillary endothelial corpus cavernosum cells to produce enough Nitric Oxide for a good erection, enough for intercourse; good, maybe, for mild ED; won't impact Vivus " erection on demand ".

TA